SC 13D

Company

Viridian Therapeutics, Inc.\DE

Filed

January 5, 2021

Accession Number

0001193125-21-001414

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →